This site is intended for U.S. healthcare professionals.
Menu
Close
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Example of description text sitting alongside header
Help your eligible patients save on PAXLOVID by downloading up to 5 cards now. Each card has a unique identification number, so please make sure to distribute 1 to each patient. Then have them follow the activation instructions found on the card.
Your co-pay card(s) have been emailed to: {{emailTo}}
Your co-pay card download should begin now. Each offer has a unique identification number and can only be used once.
If your download does not start, please click here to download again.
Visit the PAXCESS Portal to enroll your patients in the PAXCESS Patient Support Program.
-Pharmacy Guidance for PAXLOVID Commercialization
-PAXLOVID Billing and Coding Guide
-HCP & Patient PAXLOVID Packaging Education Flashcards
-Healthcare Provider DDI Pocket Resource
-PAXCESS Patient Brochure
-PAXCESS HCP Brochure
-PAXCESS Patient Support Program One-Pager
-PAXCESS Patient Support Program Flashcard
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.
Drugs that are strong CYP3A inducers: PAXLOVID cannot be started immediately after discontinuation of any of the following medications due to the delayed offset of the recently discontinued CYP3A inducer:
Limitations of Use
PAXLOVID is not approved for use as pre-exposure or post-exposure prophylaxis for prevention of COVID-19.